Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin

被引:0
|
作者
M. Depré
A. Van Hecken
M. Oeyen
I. De Lepeleire
T. Laethem
P. Rothenberg
K. J. Petty
A. Majumdar
T. Crumley
D. Panebianco
A. Bergman
J. N. de Hoon
机构
[1] U. Z. Gasthuisberg (K. U. Leuven),Center for Clinical Pharmacology
[2] Merck Research Laboratories,undefined
[3] Merck Research Laboratories,undefined
[4] Merck Research Laboratories,undefined
[5] Merck Research Laboratories,undefined
关键词
Aprepitant; Antiemetic; Warfarin; Pharmacodynamics; Pharmacokinetics; Drug interaction; Cytochrome;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:341 / 346
页数:5
相关论文
共 50 条
  • [31] Effect of continuous subcutaneous treprostinil therapy on the pharmacodynamics and pharmacokinetics of warfarin
    Wade, M
    Hunt, TL
    Lai, AA
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 41 (06) : 908 - 915
  • [32] Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
    Jiang, XM
    Williams, KM
    Liauw, WS
    Ammit, AJ
    Roufogalis, BD
    Duke, CC
    Day, RO
    McLachlan, AJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (04) : 425 - 432
  • [33] Ambrisentan has no clinically relevant effect on the pharmacokinetics or pharmacodynamics of warfarin
    Gerber, Michael J.
    Dufton, Christopher
    Pentikis, Helen
    Zhu, Li
    Ghofrani, Hossein A.
    CHEST, 2006, 130 (04) : 256S - 256S
  • [34] The effect of warfarin on the pharmacokinetics and pharmacodynamics of napsagatran in healthy male volunteers
    R.A. Faaij
    J.M.T. van Griensven
    R.C. Schoemaker
    T. Goggin
    A. Guenzi
    J.M. Kroon
    J. Burggraaf
    A.F. Cohen
    European Journal of Clinical Pharmacology, 2001, 57 : 25 - 29
  • [35] Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of racemic warfarin in healthy subjects
    Lilja, JJ
    Backman, JT
    Neuvonen, PJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (04) : 433 - 439
  • [36] Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer
    Camidge, R
    Reigner, B
    Cassidy, J
    Grange, S
    Abt, M
    Weidekamm, E
    Jodrell, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) : 4719 - 4725
  • [37] Study of the effect of miglitol on the pharmacokinetics and pharmacodynamics of warfarin in healthy males
    Schall, R
    Muller, FO
    Hundt, HKL
    Duursema, L
    Groenewoud, G
    Middle, MV
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1996, 46 (01): : 41 - 46
  • [38] Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits
    Kura, Raghunandan Reddy
    Kilari, Eswar Kumar
    Shaik, Mastan
    PEERJ, 2018, 6
  • [39] The effects of acetaminophen on pharmacokinetics and pharmacodynamics of warfarin
    Kwan, D
    Bartle, WR
    Walker, SE
    JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (01): : 68 - 75
  • [40] Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
    Krishna, Rajesh
    Stypinski, Daria
    Ali, Melissa
    Garg, Amit
    Cote, Josee
    Maes, Andrea
    DeGroot, Bruce
    Liu, Yang
    Li, Susie
    Connolly, Sandra M.
    Wagner, John A.
    Stoch, S. Aubrey
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (01) : 116 - 124